These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 20462091)

  • 1. 2.5% and 10% phenylephrine for mydriasis in diabetic patients with darkly pigmented irides.
    Suwan-Apichon O; Ratanapakorn T; Panjaphongse R; Sinawat S; Sanguansak T; Yospaiboon Y
    J Med Assoc Thai; 2010 Apr; 93(4):467-73. PubMed ID: 20462091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized double-blind study of phenylephrine 2.5% vs 10% on pupillary dilation.
    Yospaiboon Y; Luanratanakorn P; Noppawinyoowong C
    J Med Assoc Thai; 2004 Nov; 87(11):1380-4. PubMed ID: 15825717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single dose of 1% tropicamide and 10% phenylephrine for pupil dilation.
    Ratanapakorn T; Yospaiboon Y; Chaisrisawadsuk N
    J Med Assoc Thai; 2006 Nov; 89(11):1934-9. PubMed ID: 17205877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of efficacy and tolerance between 1% hydroxyamphetamine plus 0.25% tropicamide (Paremyd) and 0.5% tropicamide combined with 2.5% phenylephrine.
    Zeise MM; McDougall BW; Bartlett JD; Corliss D; Mitten L
    J Am Optom Assoc; 1996 Nov; 67(11):681-9. PubMed ID: 8979662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the cardiovascular effects of 2.5% phenylephrine and 10% phenylephrine during ophthalmic surgery.
    Malhotra R; Banerjee G; Brampton W; Price NC
    Eye (Lond); 1998; 12 ( Pt 6)():973-5. PubMed ID: 10325999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between obtained mydriasis in type 2 diabetics and non-diabetic patients.
    Coblentz J; Motta MM; Fernandes BF; Burnier MN; Vianna RN
    Curr Eye Res; 2009 Nov; 34(11):925-7. PubMed ID: 19958108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mydriatic and cardiovascular effects of phenylephrine 2.5% versus phenylephrine 10%, both associated with tropicamide 1%.
    Motta MM; Coblentz J; Fernandes BF; Burnier MN
    Ophthalmic Res; 2009; 42(2):87-9. PubMed ID: 19478547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the effectiveness of mydriasis by two instillation methods of combined 0.75% tropicamide and 2.5% phenylephrine eye drop in preterm infants.
    Phamonvaechavan P; Chutasmit K; Damrongrak P; Koukiatkul S; Wongkiatkajorn T; Ngerncham S
    J Med Assoc Thai; 2012 Apr; 95 Suppl 4():S1-7. PubMed ID: 22696845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination cyclopentolate and phenylephrine for mydriasis in premature infants with heavily pigmented irides.
    Khoo BK; Koh A; Cheong P; Ho NK
    J Pediatr Ophthalmol Strabismus; 2000; 37(1):15-20. PubMed ID: 10714690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Biochemical stress monitoring during cataract surgery; phenylephrine 10% shows no changes in serum-catecholamines in comparison with phenylephrine 5%].
    Schlichtenbrede FC; Burkhardt KU; Bartram MC; Wiedemann R
    Klin Monbl Augenheilkd; 2001 Jul; 218(7):479-83. PubMed ID: 11512247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of mydriatics on intraocular pressure and pupil size in the normal feline eye.
    Stadtbäumer K; Frommlet F; Nell B
    Vet Ophthalmol; 2006; 9(4):233-7. PubMed ID: 16771758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pupil dilatation after single and triple doses of mydriatic agent in preterm infants.
    Punyawattanaporn A; Tengtrisorn S; Sangsupawanich P
    J Med Assoc Thai; 2009 Nov; 92(11):1458-62. PubMed ID: 19938737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Perioperative circulatory side effects of topical 5% phenylephrine for mydriasis].
    Hempel S; Senn P; Pakdaman F; Schmid MK; Suppiger M; Schipper I
    Klin Monbl Augenheilkd; 1999 Nov; 215(5):298-304. PubMed ID: 10609245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a new preoperative ophthalmic solution.
    Hirowatari T; Tokuda K; Kamei Y; Miyazaki Y; Matsubara M
    Can J Ophthalmol; 2005 Feb; 40(1):58-62. PubMed ID: 15825531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ophthalmic Insert versus Eye Drops for Mydriasis in Neonates: A Randomized Clinical Trial.
    Bremond-Gignac D; Jacqz-Aigrain E; Abdoul H; Daruich A; Beresniak A; Baud O; Alberti C;
    Neonatology; 2019; 115(2):142-148. PubMed ID: 30481790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the efficacy and safety of the ophthalmic insert Mydriasert in patients undergoing retinal angiography.
    Cagini C; Caricato A; Tosi G; Pascale A; Cesari C; Fiore T
    Eur J Ophthalmol; 2014; 24(5):728-34. PubMed ID: 24557758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obtained mydriasis in long-term type 2 diabetic patients.
    Lei HL; Yang KJ; Sun CC; Chen CH; Huang BY; Ng SC; Yeung L
    J Ocul Pharmacol Ther; 2011 Dec; 27(6):599-602. PubMed ID: 21879887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacodynamics of a new ophthalmic mydriatic insert in healthy volunteers: potential alternative as drug delivery system prior to cataract surgery.
    Mouly S; Mahé I; Haouchine B; Sanson-le-Pors MJ; Blain P; Tillet Y; Dewailly J; Mongold JJ; Bergmann JF
    Basic Clin Pharmacol Toxicol; 2006 Jun; 98(6):547-54. PubMed ID: 16700815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A combination solution for routine pupillary dilation.
    Krumholz DM; Portello JK; Rosenfield M; Rosenbaum JD
    Optometry; 2006 Jul; 77(7):350-3. PubMed ID: 16814239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective degree of mydriasis with phenylephrine and tropicamide.
    Levine L
    Am J Optom Physiol Opt; 1976 Dec; 53(12):774-85. PubMed ID: 1015526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.